Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH.
ABOUT US
Executive Team
Our management team has broad expertise across scientific and business operations, inventing compounds, and advancing product candidates through clinical development.
President And Chief Executive Officer
Chief Financial Officer
Chief Scientific Officer
Chief Medical Officer
Chief Technology Officer
Chief Business Officer
Senior Leadership Team
Vice President, Quality and Compliance Management
Vice President, Clinical Operations
Vice President, Clinical Development
Vice President, Product Development
Vice President, Commercial Strategy And Portfolio Development
Vice President, Finance
Corporate Controller and Acting CFO
Vice President, Biostatistics and Data Management
Board of Directors
Chairman Of The Board
Director
Director
Director
President And Chief Executive Officer
Director
Director
Scientific Advisory Boards
Obesity
Co-Director Of The Center For Weight Management And Wellness (CWMW), Division Of Endocrinology, Diabetes, And Hypertension, Brigham And Women’s Hospital
Sanford I. Weill Professor Of Metabolic Research And Director Of The Comprehensive Weight Control Center, Division Of Endocrinology, Diabetes & Metabolism, Weill Cornell Medicine
Medical Director And Principal Investigator Of Velocity Clinical Research (Formerly National Research Institute)
William H. Danforth Professor Of Medicine, Director Of The Center For Human Nutrition, Director Of The Center For Applied Research Sciences, Chief Of The Division Of Geriatrics And Nutritional Sciences, And Director Of The Weight Management Program, Washington University School Of Medicine, St. Louis, Missouri
Professor Of Medicine And Medicine Education At Northwestern University Feinberg School Of Medicine, And Director Of The Center For Lifestyle Medicine
Professor Emerita, Pennington Biomedical, Baton Rouge, Louisiana
MASH
David W Crabb Professor & Vice President For Academic Affairs, Indiana University School Of Medicine & Indiana University Health
Professor Of Medicine, Director Of Hepatology, At University Of California At San Diego
Director, Cedars-Sinai Medical Center Fatty Liver Program
Partnerships
We believe strategic partnerships break barriers to innovation and we continuously evaluate partnership opportunities. Contact Raymond Jordt, Chief Business Officer, for partnership inquiries.
For partnership opportunities contact:
Raymond Jordt
Chief Business Officer
rjordt@altimmune.com